{"entity":{"id":"nct07629609","kind":"trial","name":"BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer","aka":["BEFAST"],"tldr":"A phase 2 trial in pancreatic cancer, run by Barbara Malene Fischer, now recruiting.","summary":"BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer is a phase 2, interventional study registered as NCT07629609 by Barbara Malene Fischer, with a registry enrolment figure of 90 participants, started 2024-01-16 and due to reach its primary completion in 2027-01. Interventions recorded: [68Ga]Ga-FAPI-46. Conditions listed: Pancreatic Cancer, Adult; Gastroesophageal Cancer (GC). Primary outcome: Sensitivity of [68Ga]Ga-FAPI-46 Total Body PET/CT. Pancreatic eligibility wording from the registry: \"Patients with suspected pancreatic cancer based on morphological findings on standard imaging\". Sites: Denmark. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07629609","url":"https://clinicaltrials.gov/study/NCT07629609"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["pancreatic"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07629609","phase":"2","setting":"[68Ga]Ga-FAPI Total Body PET/CT for Improving Diagnostic Sensitivity and Preoperative Staging in Gastroesophageal Cancer and Pancreatic Cancer","sponsor":"Barbara Malene Fischer","enrolled":90,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07629609/","neighbours":{"cancer":[{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}